ArticleOncotarget2015

IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules.

Shanzhou Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.